ClinicalTrials.Veeva

Menu

Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Hyperparathyroidism, Secondary
Roux-en-Y Gastric Bypass

Treatments

Dietary Supplement: Calcium Carbonate
Procedure: Roux-en-Y gastric bypass
Dietary Supplement: Calcium Citrate
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT02830789
20160610

Details and patient eligibility

About

This study investigates whether calcium citrate or calcium carbonate are the optimal supplement to treat secondary hyperparathyroidism following Roux-en-Y gastric bypass operation.

Half of the participants will be randomized to receive calcium citrate, while the other half will receive calcium carbonate. The study will be double blinded.

Enrollment

38 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Roux-en-Y gastric bypass operation ≥12 months ago
  • Parathyroid hormone > 6.9 pmol/l
  • Vitamin D > 50 nmol/l
  • P-Calcium [1.18-1.32] mmol/l

Exclusion criteria

  • Liver disease
  • Renal disease
  • Hypercalcemia
  • Untreated thyroid disease
  • Parathyroid disease except secondary hyperparathyroidism
  • Use of diuretics, bisphosphonates, calcitonin, teriparatide, oral corticosteroids, anabolic steroids, calcimimetics, lithium, strontium, denosumab or anticonvulsants within 1 year of inclusion
  • abusing alcohol

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

38 participants in 2 patient groups

Calcium Carbonate
Experimental group
Description:
1 tablet Unikalk Forte + 1 placebo tablet by mouth three times daily equal to 1200 mg elementary calcium and 57 µg Vitamin D3
Treatment:
Dietary Supplement: Placebo
Procedure: Roux-en-Y gastric bypass
Dietary Supplement: Calcium Carbonate
Calcium Citrate
Experimental group
Description:
2 tablets Unikalk Citrat by mouth three times daily equal to 1200 mg elementary calcium and 60 µg Vitamin D3
Treatment:
Procedure: Roux-en-Y gastric bypass
Dietary Supplement: Calcium Citrate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems